Resultados da pesquisa - Lindsey R. Sangaralingham

Refinar resultados
  1. 1
    Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

    Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study Por Neena S. Abraham, Peter A. Noseworthy, Xiaoxi Yao, Lindsey R. Sangaralingham, Nilay D. Shah

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure

    Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure Por Lindsey R. Sangaralingham, S. Jeson Sangaralingham, Nilay D. Shah, Xiaoxi Yao, Shannon M. Dunlay

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

    Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction Por Xiaoxi Yao, Nilay D. Shah, Lindsey R. Sangaralingham, Bernard J. Gersh, Peter A. Noseworthy

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients

    Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients Por Ravi Parikh, Joseph S. Ross, Lindsey R. Sangaralingham, Ron A. Adelman, Nilay D. Shah, Andrew J. Barkmeier

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction

    Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction Por Nicholas Y. Tan, Lindsey R. Sangaralingham, S. Jeson Sangaralingham, Xiaoxi Yao, Nilay D. Shah, Shannon M. Dunlay

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice

    Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice Por Maya H. Maloney, Stephanie Payne, Jeph Herrin, Lindsey R. Sangaralingham, Nilay D. Shah, Andrew J. Barkmeier

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database

    Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database Por Alina M. Allen, Holly K. Van Houten, Lindsey R. Sangaralingham, Jayant A. Talwalkar, Rozalina G. McCoy

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer

    A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer Por Elizabeth Cathcart-Rake, Lindsey R. Sangaralingham, Henry J. Henk, Nilay D. Shah, Irbaz Bin Riaz, Aaron S. Mansfield

    Publicado em 2020
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis

    Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis Por Taylor Teague, Stephanie Payne, Bryan T. Kelly, Timothy Dempsey, Rozalina G. McCoy, Lindsey R. Sangaralingham, Andrew H. Limper

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

    Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation Por Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham, Fernanda Bellolio, Robert D. McBane, Nilay D. Shah, Peter A. Noseworthy

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation

    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation Por Xiaoxi Yao, Navdeep Tangri, Bernard J. Gersh, Lindsey R. Sangaralingham, Nilay D. Shah, Karl A. Nath, Peter A. Noseworthy

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment

    Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment Por Michelle Herberts, Taylor Teague, Viengneesee Thao, Lindsey R. Sangaralingham, Henry J. Henk, Kevin T Hovde, Timothy Dempsey, Andrew H. Limper

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis

    Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis Por Siddharth Singh, Herbert C. Heien, Lindsey R. Sangaralingham, Stephanie R. Schilz, Michael D. Kappelman, Nilay D. Shah, Edward V. Loftus

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease

    Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease Por Siddharth Singh, Herbert C. Heien, Lindsey R. Sangaralingham, Stephanie R. Schilz, Michael D. Kappelman, Nilay D. Shah, Edward V. Loftus

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Association of Area-Level Socioeconomic Deprivation With Hypoglycemic and Hyperglycemic Crises in US Adults With Diabetes

    Association of Area-Level Socioeconomic Deprivation With Hypoglycemic and Hyperglycemic Crises in US Adults With Diabetes Por Shaheen Kurani, Herbert C. Heien, Lindsey R. Sangaralingham, Jonathan Inselman, Nilay D. Shah, Sherita Hill Golden, Rozalina G. McCoy

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Myotonic Dystrophy (<scp>DM</scp>) Burden of Disease: A Retrospective Study of Healthcare Costs and Utilization by Individuals With <scp>DM</scp>

    Myotonic Dystrophy (<scp>DM</scp>) Burden of Disease: A Retrospective Study of Healthcare Costs and Utilization by Individuals With <scp>DM</scp> Por Jennifer M. Martinez‐Thompson, W. Oliver Tobin, Hayley J. Dykhoff, Lindsey R. Sangaralingham, Molly White, Duygu Selcen, Bijan J. Borah

    Publicado em 2025
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age

    Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age Por Neena S. Abraham, Peter A. Noseworthy, Jonathan Inselman, Jeph Herrin, Xiaoxi Yao, Lindsey R. Sangaralingham, Gabriella Cornish, Che Ngufor, Nilay D. Shah

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study

    Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study Por Rozalina G. McCoy, Hayley J. Dykhoff, Lindsey R. Sangaralingham, Joseph S. Ross, Pinar Karaca‐Mandic, Víctor M. Montori, Nilay D. Shah

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort

    Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort Por Yu Shi, Lindsay R. Hunter Guevara, Hayley J. Dykhoff, Lindsey R. Sangaralingham, Sean M. Phelan, Michael J. Zaccariello, David O. Warner

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission

    Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission Por Fernanda Bellolio, Herbert C. Heien, Lindsey R. Sangaralingham, Molly M. Jeffery, Ronna L. Campbell, Daniel Cabrera, Nilay D. Shah, Erik P. Hess

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: